Douglas R. Langbehn
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
2013/05/09 by Sarah J Tabrizi, Sarah J. Tabrizi, Rachael I. Scahill +20 · 5 citations
Medicine · Neuroscience · #Attention Deficit Hyperactivity Disorder #Genetic Neurodegenerative Diseases #Parkinson's Disease Mechanisms and Treatments
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
2011/12/08 by Sarah J. Tabrizi, Sarah J Tabrizi, Ralf Reilmann +24 · 2 citations
Medicine · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Genetic Neurodegenerative Diseases #Parkinson's Disease Mechanisms and Treatments
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
2018/12/15 by Ralf Reilmann, Andrew McGarry, Igor D Grachev +146 · 1 citation
Medicine · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Genetic Neurodegenerative Diseases #Neurological disorders and treatments
- Association of CAG Repeats With Long-term Progression in Huntington Disease
2019/08/12 by Douglas R. Langbehn, Julie C. Stout, Sarah Gregory +14 · 1 citation
Medicine · Neuroscience · Psychology · #Allele #Amyotrophic Lateral Sclerosis Research #Biology #Cognition #Disease #Gene #Genetic Neurodegenerative Diseases #Genetics #Huntington's disease #Internal medicine #Medicine #Parkinson's Disease Mechanisms and Treatments #Psychiatry #Psychology #Trinucleotide repeat expansion
- Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis
2017/10/03 by Jeffrey D. Long, James A. Mills, Blair R. Leavitt +10 · 1 citation
Medicine · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Clinical trial #Cohort #Cohort study #Genetic Neurodegenerative Diseases #Internal medicine #Medicine #Parkinson's Disease Mechanisms and Treatments